Interferon-γ-Induced Nitric Oxide Synthase-2 Contributes to Blood/Brain Barrier Dysfunction and Acute Mortality in

Belinda Yau1, Andrew J Mitchell1,2, Lay Khoon Too1

  • 11 Molecular Immunopathology Unit, School of Medical Sciences, Sydney Medical School, University of Sydney , Sydney, New South Wales, Australia .

Insights

Interferon-gamma (IFNγ) drives nitric oxide synthase-2 (NOS2) expression, worsening pneumococcal meningitis (PM) in mice. Blocking IFNγ or NOS2 improved survival and reduced blood-brain barrier damage, highlighting a key pathogenic pathway.

Area of Science:

  • Neuroscience
  • Immunology
  • Infectious Diseases

Background:

  • The proinflammatory cytokine interferon-gamma (IFNγ) is implicated in experimental pneumococcal meningitis (PM) pathogenesis.
  • Investigating the role of IFNγ-driven nitric oxide synthase-2 (NOS2) in murine PM is crucial.

Purpose of the Study:

  • To elucidate the role of IFNγ-driven NOS2 in the pathogenesis of experimental murine PM.
  • To assess the impact of IFNγ and NOS2 on survival rates and blood-brain barrier (BBB) permeability during PM.

Main Methods:

  • Utilized an experimental murine PM model with Streptococcus pneumoniae (WU2 strain).
  • Employed wild-type mice, anti-IFNγ antibody treatment, and IFNγ and NOS2 gene knockout (GKO) mice.
  • Monitored survival rates and measured BBB permeability at 48 hours post-inoculation.

Main Results:

  • IFNγ deficiency significantly increased survival rates (approx. 3-fold) in PM models.
  • Brain NOS2 mRNA expression was elevated in an IFNγ-dependent manner.
  • NOS2 GKO mice showed delayed mortality, and both IFNγ GKO and NOS2 GKO mice exhibited reduced BBB dysfunction.

Conclusions:

  • IFNγ-dependent NOS2 expression contributes to BBB breakdown in murine PM.
  • Targeting the IFNγ-NOS2 pathway may offer therapeutic strategies for PM.
  • IFNγ plays a critical role in PM pathogenesis by inducing NOS2, leading to BBB disruption and mortality.